No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
CUV Clinuvel Pharmaceuticals Ltd
- 11.250
- -0.290-2.51%
20min DelayTrading Jan 13 14:00 AET
563.18MMarket Cap16.12P/E (Static)
11.460High11.160Low96.02KVolume11.450Open11.540Pre Close1.08MTurnover17.65252wk High0.23%Turnover Ratio50.06MShares11.16052wk Low0.698EPS TTM465.41MFloat Cap45.422Historical High16.12P/E (Static)41.37MShs Float0.173Historical Low0.698EPS LYR2.60%Amplitude0.05Dividend TTM2.77P/B1Lot Size0.44%Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Clinuvel Pharmaceuticals to Prioritize Programs With Highest Likelihood of Regulatory Approval, Commercial Success
Clinuvel Pharmaceuticals Ltd (CLVLF) (Q4 2024) Earnings Call Highlights: Record Revenue and ...
Clinuvel Files New Drug Submission to Health Canada for Metabolic Disorder Drug Approval
Clinuvel Pharmaceuticals (ASX:CUV) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Clinuvel Price Target Cut 4% to A$30.16/Share by Wilsons
Guess Which ASX All Ords Healthcare Share Just Rocketed 13% on Its FY 2024 Results!
Heat List
AU
Overall
Symbol
Price
% Chg
No Data
